Sophia Genetics SA

NASDAQ SOPH

Data sourced from iex and EODHD
Download Data

Sophia Genetics SA Income Statement 2020 - 2024

This table shows the Income Statement for Sophia Genetics SA going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue
M 64 62 59 54 51 48 45 44 42 40 37 34 30 28 21 13 7
Cost of Revenue
M 21 19 18 17 16 16 17 16 16 15 14 13 11 11 8 5 3
Gross Profit
M 44 43 41 37 34 31 28 28 26 25 23 21 19 18 13 9 5
Operating Expenses
M 118 118 112 115 116 119 122 118 109 97 85 72 61 55 39 25 14
Selling, General, and Administrative Expenses (SG&A)
M 53 53 54 54 55 56 55 54 47 42 35 28 24 19 12 8 4
Research and Development (R&D) Expenses
M 37 37 34 35 35 35 35 32 30 27 25 23 20 19 13 8 5
Other Operating Expenses
M 28 28 24 26 26 28 32 32 32 29 24 21 17 18 13 9 6
Costs and Expenses
M 98 98 94 97 100 103 106 102 93 81 71 58 49 44 31 20 11
Operating Income
M -74 -75 -71 -78 -82 -88 -94 -91 -82 -71 -62 -51 -42 -37 -26 -17 -10
Interest Expense
M 1 2 3 3 2 2 2 2 3 5 6 7 5 5 3 2 1
Non-operating Income/Expense
M 2 -4 2 -1 0 0 -2 -2 -4 -2 -2 -3 -2 -4 -3 -2 -1
EBT
M -72 -78 -69 -79 -82 -88 -95 -93 -86 -74 -64 -54 -43 -41 -29 -18 -11
Income Tax Provision
M 1 0 0 0 0 0 0 0 0 0 -1 -2 -2 -2 0 0 0
Income after Tax
M -73 -79 -69 -78 -82 -87 -95 -93 -86 -74 -63 -52 -41 -39 -29 -18 -11
Non-Controlling Interest
M 0 2 2 2 2 0 0 0 0 0 0 0 0 0 0 0 -
Net Income
M -35 -57 -71 -80 -83 -87 -95 -93 -86 -74 -52 -42 -31 -29 -29 -18 -11
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 65,027,668.50 64,761,178.50 64,508,279.00 64,288,149.00 64,185,869.00 64,098,058.75 61,868,284.75 60,863,425.00 60,675,561.25 56,707,507.00 54,887,394.50 51,849,087.50 48,019,413.00 45,608,848.25 44,805,326.67 43,198,283.50 38,377,154.00
EBITDA
M -66 -67 -65 -72 -77 -84 -90 -87 -80 -69 -62 -51 -42 -38 -24 -16 -9
Depreciation and Amortization
M 9 8 8 7 6 6 5 5 4 4 3 3 2 2 2 1 1
EBIT
M -74 -75 -73 -80 -84 -89 -95 -92 -84 -73 -65 -54 -45 -40 -26 -17 -10
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -1.24 -0.78 -0.32 0.34 0.43 0.34 0.49 -0.20 -0.26 -0.38 2.89 3.47 3.47 3.78 -0.12 -0.20 -0.17
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit Margin
% 67.91 68.77 69.31 67.68 67.32 65.42 63.04 63.18 62.15 62.35 62.34 61.43 62.89 62.51 62.54 64.05 61.06
Operating Income Margin
% -116.39 -121.19 -121.36 -146.73 -165.03 -188.10 -207.95 -206.69 -194.21 -175.76 -163.75 -147.16 -137.80 -130.84 -126.43 -123.86 -128.71
Net Income Margin
% -113.46 -126.71 -121.13 -149.96 -167.31 -187.68 -210.44 -211.68 -203.96 -180.58 -175.63 -155.94 -139.97 -139.88 -139.88 -136.81 -140.85
EBITDA Ratio
% -103.09 -107.77 -110.84 -136.48 -155.57 -179.29 -199.44 -198.88 -187.64 -170.03 -165.24 -148.92 -138.96 -131.94 -117.88 -115.32 -120.89
EBIT Ratio
% -116.39 -121.19 -124.26 -149.62 -167.93 -191.00 -211.06 -209.80 -197.32 -178.87 -173.32 -156.73 -147.37 -140.40 -126.43 -123.86 -128.71
EBT Ratio
% -112.64 -126.50 -117.80 -147.32 -164.80 -187.86 -211.34 -211.20 -203.37 -180.04 -169.54 -155.95 -143.99 -144.35 -139.72 -136.54 -140.61

StockViz Staff

September 16, 2024

Any question? Send us an email